Interaction of von Hippel-Lindau tumor suppressor gene product with elongin.
Cell Biology and Metabolism Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.
A
A
Pause
T
T
Aso
W M
WM
Linehan
J W
JW
Conaway
R C
RC
Conaway
R D
RD
Klausner
D003001:Cloning, Molecular; D000075065:Elongin; D004926:Escherichia coli; D016147:Genes, Tumor Suppressor; D006639:Histidine; D006801:Humans; D008025:Ligases; D009838:Oligodeoxyribonucleotides; D014176:Protein Biosynthesis; D011506:Proteins / Q000302:isolation & purification / Q000378:metabolism*; D012319:RNA Polymerase II / Q000378:metabolism*; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000302:isolation & purification / Q000378:metabolism; D016324:Sequence Tagged Sites; D013698:Templates, Genetic; D014157:Transcription Factors / Q000096:biosynthesis / Q000302:isolation & purification / Q000378:metabolism*; D014158:Transcription, Genetic; D025521:Tumor Suppressor Proteins; D044767:Ubiquitin-Protein Ligases; D051794:Von Hippel-Lindau Tumor Suppressor Protein
D000075065:Elongin; D009838:Oligodeoxyribonucleotides; D011506:Proteins; D011994:Recombinant Proteins; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins; C033539:oligodeoxycytidylic acid; D006639:Histidine; D044767:Ubiquitin-Protein Ligases; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D012319:RNA Polymerase II; D008025:Ligases; C497446:VHL protein, human